Evolv Technologies Holdings Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
EVLV$4.76+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $44,596 | $67,162 |
| Restricted cash | — | 275 |
| Marketable securities | 36,415 | 51,289 |
| Accounts receivable, net * | 22,030 | 22,611 |
| Inventory | 11,007 | 9,507 |
| Current portion of contract assets | 2,538 | 3,707 |
| Current portion of commission asset | 4,516 | 4,339 |
| Prepaid expenses and other current assets | 20,700 | 16,954 |
| Total current assets | 141,802 | 175,844 |
| Restricted cash, noncurrent | 275 | — |
| Contract assets, noncurrent | 307 | 451 |
| Commission asset, noncurrent | 7,000 | 7,107 |
| Property and equipment, net | 129,342 | 112,921 |
| Operating lease right-of-use assets | 2,535 | 1,195 |
| Other assets | 999 | 1,202 |
| Total assets | $282,260 | $298,720 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $15,584 | $17,400 |
| Accrued expenses and other current liabilities | 13,712 | 15,578 |
| Current portion of deferred revenue | 48,913 | 47,677 |
| Current portion of operating lease liabilities | 1,713 | 1,391 |
| Total current liabilities | 79,922 | 82,046 |
| Deferred revenue, noncurrent | 22,808 | 23,813 |
| Operating lease liabilities, noncurrent | 980 | — |
| Contingent earn-out liability | 22,220 | 29,119 |
| Contingently issuable common stock liability | 6,003 | 6,530 |
| Public warrant liability | 8,738 | 10,889 |
| Total liabilities | 140,671 | 152,397 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 100,000,000 authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | — | — |
| Common stock, $0.0001 par value; 1,100,000,000 shares authorized at March 31, 2024 and December 31, 2023; 155,356,947 and 151,310,080 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 16 | 15 |
| Additional paid-in capital | 451,731 | 444,825 |
| Accumulated other comprehensive loss | (50) | (53) |
| Accumulated deficit | (310,108) | (298,464) |
| Stockholders’ equity | 141,589 | 146,323 |
| Total liabilities and stockholders’ equity | $282,260 | $298,720 |
*Includes related party accounts receivable, net of $2.1 million and $1.7 million as of March 31, 2024 and December 31, 2023, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.